{{Rsnum
|rsid=17065323
|Chromosome=13
|position=44053652
|Orientation=plus
|GMAF=0.06474
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 97.3 | 2.7 | 0.0
| HCB | 87.6 | 12.4 | 0.0
| JPT | 88.5 | 9.7 | 1.8
| YRI | 66.9 | 29.0 | 4.1
| ASW | 66.7 | 24.6 | 8.8
| CHB | 87.6 | 12.4 | 0.0
| CHD | 89.9 | 10.1 | 0.0
| GIH | 92.1 | 6.9 | 1.0
| LWK | 71.6 | 26.6 | 1.8
| MEX | 93.1 | 6.9 | 0.0
| MKK | 53.2 | 37.2 | 9.6
| TSI | 95.1 | 4.9 | 0.0
| HapMapRevision=28
}}{{GWAS Summary
|SNP=rs17065323
|PubMedID=18759275
|Condition=Serum uric acid
|Gene=NR
|Risk Allele=
|pValue=4.00E-006
|OR=4.29
|95CI=NR) mg/dl decrease in uric acid level
|OA=1
}}

{{PharmGKB
|RSID=rs17065323
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:18759275; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Association of a common nonsynonymous variant in GLUT9 with serum uric acid levels in old order amish (Initial Sample Size: 408 women, 460 men; Replication Sample Size: NR). This variant is associated with Serum uric acid levels.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356404
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs17065323
|overall_frequency_n=12
|overall_frequency_d=128
|overall_frequency=0.09375
|n_genomes=8
|n_genomes_annotated=0
|n_haplomes=9
|n_articles=1
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=Y
|n_web_uneval=7
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}